NEW YORK, NY / ACCESS Newswire / November 21, 2025 / If you suffered a loss on your Skye Bioscience, Inc. (NASDAQ:SKYE) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/skye-bioscience-inc-lawsuit-submission-form?prid=178493&wire=1&utm_campaign=10 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or […]

NEW YORK, NY / ACCESS Newswire / November 21, 2025 / If you suffered a loss on your Avantor, Inc. (NYSE:AVTR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/avantor-inc-lawsuit-submission-form?prid=178492&wire=1&utm_campaign=4 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

The innovative fleet and trucking venture will launch in Texas with a nationwide rollout backed by SouthernPlex Group and fleet solutions company ProFleetX. Semi Repair Shop, Inc. has announced its official plans for launch, introducing a dynamic onsite trucking and fleet maintenance platform. Developed in partnership between SouthernPlex and ProFleetX, the company aims to streamline

NEW YORK, NY / ACCESS Newswire / November 21, 2025 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/dexcom-inc-lawsuit-submission-form-2?prid=178490&wire=1&utm_campaign=24 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

NEW YORK, NY / ACCESS Newswire / November 21, 2025 / If you suffered a loss on your James Hardie Industries plc. (NYSE:JHX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/james-hardie-industries-plc-lawsuit-submission-form?prid=178489&wire=1&utm_campaign=9 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com

NEW YORK, NY / ACCESS Newswire / November 21, 2025 / If you suffered a loss on your MoonLake Immunotherapeutics (NASDAQ:MLTX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/moonlake-lawsuit-submission-form?prid=178491&wire=1&utm_campaign=9 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

Advanced Composite Materials Market Size to Worth USD 102.15 Bn by 2035 According to Towards Chemical and Materials Consulting, the global advanced composite materials market is projected to grow from USD 45.39 billion in 2025 to USD 102.15 billion by 2035, growing at a compound annual growth rate (CAGR) of 8.45% over the forecast period

Subotiz, an emerging fintech platform powering AI-driven subscription and payment solutions, was recently featured at the Singapore FinTech Festival (SFF 2025), a global stage for innovation in finance and technology. https://mma.prnewswire.com/media/2776188/Subotiz_Logo.jpg At SFF 2025, a participating exhibitor demonstrated advanced subscription and billing models using Subotiz's technology in their on-site demos, giving attendees a real-time look

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit againstSkye Bioscience, Inc. (“Skye” or “the Company”) (NASDAQ: SKYE) forviolations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. https://mma.prnewswire.com/media/1396534/Schall_Firm_Logo.jpg Investors who purchased the

The DJS Law Group reminds investors of a class action lawsuit against DexCom, Inc. (“DexCom ” or “the Company”) (NASDAQ: DXCM ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of DXCM during the